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This Month in the Journal
In this month’s issue, we feature four reviews on the
genetics of neurological development and disease. Jiang
et al. (p. 1) begin the series by discussing the discovery
of the imprinted UBE3A gene as the causative gene in
Angelman syndrome (AS), the development of mouse
models of AS, and the regulation of UBE3A imprinting.
AS can occur through a remarkable number of genetic
mechanisms, and Jiang et al. introduce a unifying no-
menclature to describe them all. Sisodia et al. (p. 7) and
Giulian (p. 13) both are concerned with the development
of Alzheimer disease (AD). Sisodia et al. (p. 7) discuss
the presenilins, intracellular proteins that are implicated
in the pathway that generates amyloidogenic peptides
from the amyloid-precursor protein. Remarkably, pre-
senilins influence the packaging of specific proteins into
secretory vesicles in diverse organisms. Giulian describes
the role of brain microglia in the death of hippocampal
neurons, work that begins to make sense of the rela-
tionships between cognitive decline, amyloid deposition,
and apolipoprotein E polymorphisms. Fox and Walsh
(p. 19) discuss periventricular heterotopia, a develop-
mental disorder in which neurons lack the cytoskeletal
protein filamin-1 and fail to migrate. This protein has
also been studied in the slime mold Dictyostelium dis-
coideum, the subject of Saxe’s review (p. 25). Saxe re-
views the merits of this simple model eukaryote for
human disease genes, studying, in particular, the Wis-
cott-Aldrich syndrome gene, WASP.
Mutation Detection in the PKD1 Gene, by Thomas et
al. (p. 39)
Loss-of-function alleles of the PKD1 gene cause poly-
cystic kidney disease, a dominantly inherited progressive
renal disorder that also causes cysts in the liver and
pancreas. Somatic second hits may promote cyst for-
mation by abolishing residual expression of PKD1 in
isolated domains of each of these organs. Because the 5′
end of PKD1 is present in nearly identical form in mul-
tiple genes, only the 3′ end of the gene has proved ame-
nable to systematic mutation analysis. The first 15 exons
have been particularly difficult to screen, but now Tho-
mas et al. have identified in the gene a short region that
diverges from the other homologues, so that PKD1-spe-
cific PCR primers can be designed to amplify this region
from patients’ DNA. Using long-range PCR, Thomas
and colleagues amplify a 13-kb genomic fragment that
covers exons 2–15, and they identify eight likely path-
ological mutations in this portion of the gene, by se-
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quencing this product from 24 unrelated individuals
with the disorder.
The GM2A Gene Structure and Novel Mutation, by
Chen et al. (p. 77)
Premature-termination codons (PTCs) have two unex-
pected effects on steady-state mRNA distributions, as
they are measured by northern or reverse transcrip-
tion–PCR analysis. First, they generally cause the af-
fected mRNA to be unstable. Second, in some instances,
they permit aberrantly spliced forms of the mRNA, in
which the PTC is excised from the mature message, to
accumulate in the cytoplasm. The latter effect, in par-
ticular, has been taken as evidence for an intranuclear
surveillance mechanism that alters the splicing pathway,
in response to breaks in a pre-mRNA’s open reading
frame. However, Chen and coworkers now provide sup-
port for an alternative model that does not require nu-
clear factors to be sensitive to the mRNA reading frame.
Working with cells from a child with severe GM2 gan-
gliosidosis, Chen et al. trace the defect to a nonsense
mutation in the second exon of the GM2A gene, and
they show that GM2A mRNA is expressed in a shorter
form with an in-frame deletion that removes exon 2.
Although this splicing form is not readily detected in
preparations from normal cells, the authors use a specific
restriction enzyme to prevent the full-length sequence
from being amplified, and they show that it is indeed
expressed at low levels in normal—as well as the affected
individual’s—cells. Therefore, the presence of aberrant
splicing forms in such cases may reflect the instability
of the PTC-containing mRNA, rather than a direct effect
on the splicing pathway.
CD Breakpoints 1 Mb from SOX9 by Pfeifer et al.
(p. 111)
SOX9 encodes a transcription factor related to the testis-
determination factor SRY, and defects in SOX9 cause
an autosomal dominant developmental syndrome, cam-
pomelic dysplasia. This condition apparently results
from haploinsufficiency for SOX9 expression in devel-
oping bones and testes, and it leads to skeletal dysmor-
phologies and, often, sex reversal. Although CD is often
caused by point mutations in SOX9, translocations and
inversions that break upstream of the gene can also cause
the disease. Pfeifer and colleagues have mapped the
breakpoints in 14 such cases, and they report here that
the lesions may occur at distances from 50 kb to nearly
1 Mb upstream of the gene. The authors consider the
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possibility that these distant breakpoints actually disrupt
a different gene, but, in sequencing around the affected
regions, they find no support for this notion. More likely,
Pfeifer et al. indicate, the gene is under control of an
exceptionally long regulatory domain, or else the trans-
locations drive the gene into a heterochromatic state in
which it is only weakly expressed.
Cherubism Gene on Chromosome 4p, by Mangion et
al. (p. 151); Mapping of the Gene for Cherubism, by
Tiziani et al. (p. 158)
Another long-studied skeletal disorder, cherubism, spe-
cifically affects the bones of the jaw, which develop en-
larged, poorly calcified lesions in childhood that often
regress at puberty. The condition owes its name to the
resemblance of the affected children to the full-faced
cherubs of Renaissance paintings. In this issue, two
groups link the condition to 4p16, in the vicinity of the
FGFR3 gene. Mangion et al. confine the cherubism locus
to a 3-cM interval extending to the telomere of 4p. Ti-
ziani et al. define a much larger critical region that ap-
pears to exclude the two most telomeric markers on 4p,
so these data could be used to narrow the region of
interest in the other report. Both groups cite FGFR3 as
a candidate gene, noting that mice that lack Fgfr3 ex-
pression exhibit generalized bone overgrowth. If this
gene is indeed involved in cherubism, it will be important
to determine how the effects of the mutation are limited,
spatially and temporally.
Sequence Diversity in Human Genes, by Cambien et
al. (p. 183)
Cambien and colleagues look toward postgenomic re-
search in this exploration of large-scale sequence diver-
sity. For mapping genes of modest effect, intragenic se-
quence variation may be at least as useful as randomly
distributed single-nucleotide polymorphisms, but rela-
tively little is known about the extent of normal varia-
tion in most coding and regulatory sequences. Cambien
et al. begin to address this question with 36 genes that
may be considered candidates for cardiovascular disease.
The authors use SSCP to discover 164 polymorphisms
within this 135-kb subgenome, and they screen 750
healthy Europeans for each of these variants. They re-
port extensive linkage disequilibrium among loci within
a gene, a finding that encourages them to embark on
association studies, in the belief that disease-related var-
iants, too, are likely to be in disequilibrium with these
markers.
Expanded CAG Repeats in General Populations, by
Deka et al. (p. 192)
Repeat-expansion detection (RED) is a strategy for find-
ing unstable repeats that might, like the CAG trinucle-
otide repeats underlying various inherited ataxias, cause
intergenerational anticipation in human diseases. Un-
fortunately, two loci, ERDA1 on 17q and SEF2-1 on
18q, contain long and highly unstable CAG repeats. Spu-
rious associations between disease phenotypes and
changes in CAG repeat length at these loci greatly com-
plicate the detection of pathological repeat expansions,
leading some critics to declare that RED is dead. Deka
and coworkers have followed the distribution of CAG
repeat lengths and the meiotic instability of one of these
troublesome loci. In ERDA1, maternal transmission fa-
vors expansion, and paternal transmission favors con-
traction, of the repeat, and the presence of interruptions
in the CAG repeat allows an intermediate-length repeat
to be transmitted stably across generations. Deka et al.’s
finding that repeats in the range of 10–40 triplets are
no more unstable than other microsatellite repeats and
that some populations are relatively free of large, un-
stable alleles may permit the use of RED in selected
groups of subjects.
Detection of Parent-of-Origin Effects, by Weinberg (p.
229)
Parent-of-origin (PO) effects occur when a child’s risk
of exhibiting a genetic disease is influenced by whether
a disease allele was derived from the mother or the father,
as when genes are imprinted. Other aspects of the pa-
rental genotypes can also influence a child’s phenotype.
In particular, maternal effects, understood as intrauter-
ine environmental influences that depend on the
mother’s genotype, do not require that any specific dis-
ease gene be transmitted to the child. Two common sta-
tistical tests used for detecting linkage, the transmission/
disequilibrium test and the likelihood-ratio test (LRT),
have been adapted to test for PO effects. Here, Weinberg
discusses limitations of these approaches, including the
difficulty in distinguishing between maternal effects and
paternal imprinting. Weinberg suggests two additional
tests, the PO-LRT and the parental asymmetry test
(PAT), and she compares them with the two existing
methods, using simulation. Based on simulations, the
PO-LRT proves to be the most generally valid of the
four tests, but it is less powerful than the others, so the
PAT is to be preferred when maternal effects can be
discounted.
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